The emergence and rapid worldwide spread of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has prompted the scientific community to rapidly develop in …

Background Mutations accrued by SARS-CoV-2 lineage P. 1—first detected in Brazil in early
January, 2021—include amino acid changes in the receptor-binding domain of the viral …

COVID-19 patients can excrete viable SARS-CoV-2 virus via urine and faeces, which has
raised concerns over the possibility of COVID-19 transmission via aerosolized contaminated …

There is an urgent need for ultrarapid testing regimens to detect the severe acute respiratory
syndrome coronavirus 2 [SARS-CoV-2] infections in real-time within seconds to stop its …

Several studies have monitored the SARS-CoV-2 variants in Brazil throughout the
pandemic. Here, we systematically reviewed and conducted a scientometric analysis of the …

Background The effects of convalescent plasma (CP) therapy in hospitalised patients with
coronavirus disease 2019 (COVID-19) remain uncertain. This study investigates the effect of …

The rapid and continuous spread of SARS-CoV-2, responsible for COVID-19, has been
challenging global health systems and many strategies have been proposed to face the …

Abstract Background Coronavirus disease 2019 (COVID‐19) convalescent plasma (CCP)
collection began in two Brazilian hospitals for treatment of severe/critical patients. Methods …

Abstract SARS-CoV-2 papain-like protease (PLpro) covers multiple functions. Beside the
cysteine-protease activity, facilitating cleavage of the viral polypeptide chain, PLpro has the …

Both T cells and B cells have been shown to be generated after infection with SARS-CoV-2
yet protocols or experimental models to study one or the other are less common. Here, we …